VaxThera awaits Invima certification for vaccine production in Rionegro

AI executive summary
The story at a glance, best enjoyed with a coffee ☕
The Antioquia-based company VaxThera is close to receiving Invima certification that will allow it to start vaccine production at its Rionegro plant.
🔔 Sign in to follow this story and get its updates.
In this story you will find
AI analysis
Why it matters
This project will directly impact the country's health security by reducing dependence on imported vaccines, allowing a faster response to health emergencies and guaranteeing the supply of the Expanded Program on Immunizations. Additionally, it will generate export opportunities to other Latin American countries.
▸▾ Rate, add sources or report this story
Sign in to rate this story and add sources.
Community annexes
Coverage of this same story by other outlets, contributed by readers and checked automatically.
Ask about this coverage
Get an AI answer grounded in reports from different outlets, with links to the sources.